跳至主要内容
临床试验/NL-OMON46851
NL-OMON46851已完成2 期

The application of contrast-enhanced ultrasound to facilitate thrombolysis in patients with acute peripheral arterial occlusions. - MUST Trial

Vrije Universiteit Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Men and women older than 18 years and younger than 85 years old
  • * Patients with a maximum of 2 weeks complaints due to lower limb ischemia due to
  • thrombosed/occluded iliofemoral, femoropopliteal or femorocrural native arteries or femoropopliteal or
  • femorocrural venous or prosthetic bypass grafts
  • * Anatomic suitability duplex ultrasound in case of iliac occlusion
  • * Patients fit for thrombolysis i.e. with acute lower limb ischemia class I and IIa according to the
  • Rutherford classification (see attachment II)
  • * Patients understand the nature of the procedure and provide written informed consent before enrolment
  • in the study

排除标准

  • * Patients with clinical complaints of acute lower limb ischemia due to thrombosis of the iliofemoral, femoropopliteal or femorocrural native arteries, or femoropopliteal or femorocrural venous or prosthetic bypass grafts more than 2 weeks
  • * Patients with iliac occlusions anatomically not suitable for duplex ultrasound
  • * Patients with thrombosed popliteal aneurysms
  • * Patients with contra-indications for the administration of antiplatelet therapy, anticoagulants or thrombolytics
  • * Recent (less than 6 weeks) ischemic stroke, cerebral bleeding or myocardial infarction
  • * Patients with recent (less than 6 weeks) surgery
  • * Severe hypertension (diastolic blood pressure greater than 110 mm Hg, systolic blood pressure higher than 200 mm Hg)
  • * Current malignancy or severe comorbid condition with a life expectancy of less than 6 months
  • * Patients with uncorrected bleeding disorders (gastrointestinal ulcer, menorrhagia, liver failure)
  • * Women with child-bearing potential not taking adequate contraceptives or currently breastfeeding
  • * Pregnancy
  • * Patients who are currently participating in another investigational drug or device study
  • * Patients younger than 18 years or older than 85 years
  • * Patients with contra-indications for Luminity microbubbles i.e.
  • * Hypersensitivity to perflutren or other components of Luminity
  • * Recent acute coronary syndrome or clinically unstable ischemic cardiac disease, including: evolving or ongoing myocardial infarction, typical angina at rest within last 7 days, significant worsening of cardiac symptoms within last 7 days, recent coronary artery intervention or other factors suggesting clinical instability (for example, recent deterioration of ECG, laboratory or clinical findings), acute cardiac failure, Class III/IV cardiac failure, or severe rhythm disorders
  • * Patients known to have right-to-left shunts, severe pulmonary hypertension (pulmonary artery pressure >90 mmHg), uncontrolled systemic hypertension, and in patients with GOLD Stage IV COPD, diffuse interstitial fibrosis or adult respiratory distress syndrome.

研究者

相似试验

The application of contrast-enhanced ultrasound to... | 临床试验